2025-08-29 - Analysis Report
Okay, here's a report analyzing Hims & Hers Health Inc (HIMS) based on the provided data.

## Hims & Hers Health Inc (HIMS) Analysis

**Ticker:** HIMS
**Company Overview:** Hims & Hers Health Inc. is a telehealth company that offers personalized health and wellness solutions direct to consumers.

### 1. Performance Relative to S&P 500 (VOO)

*   **HIMS Cumulative Return:** 168.30%
*   **VOO Cumulative Return:** 71.19%
*   **Absolute Deviation:** 97.11%
*   **Deviation Range:** (Min: -103.8, Max: 497.6)
*   **Current Relative Deviation:** 225.1
*   **Relative Deviation Percentile:** 54.7

**Analysis:** HIMS has significantly outperformed the S&P 500 (VOO) over the period. The Relative Deviation Percentile suggests that the current outperformance is around the 54.7th percentile of its historical range, indicating that HIMS's current performance is above its historical average.

**Alpha, Beta Analysis**

| Year       | CAGR     | MDD      | Alpha    | Beta     | Cap(B) |
|------------|----------|----------|----------|----------|--------|
| 2019-2021  | -46.0%   | 51.0%    | -84.0%   | -0.0     | 1.5    |
| 2020-2022  | -15.0%   | 72.1%    | -17.0%   | -0.0     | 1.4    |
| 2021-2023  | -51.0%   | 72.1%    | -69.0%   | -0.1     | 2.0    |
| 2022-2024  | 127.0%   | 78.4%    | 101.0%   | -0.1     | 5.5    |
| 2023-2025  | 163.0%   | 79.9%    | 109.0%   | -0.1     | 10.0   |

**Analysis:**

*   **CAGR (Compound Annual Growth Rate):**  HIMS has shown periods of significant negative growth (2019-2023) followed by strong positive growth in more recent periods (2022-2025).
*   **MDD (Maximum Drawdown):**  MDD is quite high across all periods, indicating significant volatility and potential for large losses from peak to trough.
*   **Alpha:**  Alpha is generally negative in earlier periods, showing underperformance relative to the benchmark, but turns strongly positive in the later periods, indicating significant outperformance.
*   **Beta:**  Beta is consistently close to zero or slightly negative, suggesting very low correlation with the overall market.
*   **Cap(B) (Market Capitalization):**  Market capitalization has grown substantially over the observed periods, indicating increasing investor confidence.

### 2. Recent Price Action

*   **Current Price:** 44.12
*   **Previous Close:** 44.01
*   **Price Change:** 0.25
*   **5-Day Moving Average:** 44.208
*   **20-Day Moving Average:** 48.531
*   **60-Day Moving Average:** 51.6328

**Analysis:** The current price is slightly above the previous close, and close to the 5-day moving average, but is below the 20-day and 60-day moving averages. This suggests recent downward momentum and a possible short-term downward trend. The minimal price change from the previous close does not indicate any significant short-term shock or rapid fluctuation.

### 3. Market Risk and Indicators

*   **Market Risk Indicator (MRI):** 0.3266 (Low Risk)
*   **RSI (Relative Strength Index):** 28.61 (Oversold)
*   **PPO (Percentage Price Oscillator):** -0.8273
*   **Hybrid Signal:** cash_70%_Sell 0.1% of holdings (1 shares - Caution - MRI:0.33)
*   **20-Day Relative Deviation Change:** -3.5 (Short-term decline)
*   **Expected Return (vs. S&P 500):** -25.2% (Long-term)

**Analysis:**

*   **MRI:** The MRI indicates a low-risk environment.
*   **RSI:** The RSI suggests that the stock is currently oversold, potentially indicating a buying opportunity.
*   **PPO:**  The negative PPO suggests that the short-term moving average is below the long-term moving average, indicating bearish momentum.
*   **Hybrid Signal:** The hybrid signal recommends a conservative approach with a high cash ratio, reflecting caution.
*   **20-Day Relative Deviation Change:** The negative change in relative deviation reinforces the short-term downward trend.
*   **Expected Return:** The negative expected return suggests that, based on the model, HIMS is expected to underperform the S&P 500 over the long term.

### 4. Recent News & Significant Events

*   **2025-08-25:**  Major business developments, regulatory changes, or market events.
*   **2025-08-27:** Analyst discussions on recent performance and outlook.
*   **2025-08-29:** Notable stock volatility.
*   **2025-08-28:** Market experts highlight risks and opportunities.

**Analysis:** Recent news suggests significant activity around HIMS, including volatility, analyst discussions, and potential business or regulatory changes.  This warrants closer monitoring of company announcements and news sources.

### 5. Recent Earnings Analysis

| 날짜       | EPS  | 매출      |
|------------|------|-----------|
| 2025-08-04 | 0.19 | 0.54 B$   |
| 2025-05-05 | 0.22 | 0.59 B$   |
| 2024-11-04 | 0.35 | 0.40 B$   |
| 2024-08-05 | 0.06 | 0.32 B$   |
| 2025-08-04 | 0.06 | 0.32 B$   |

**Analysis:**

* **EPS (Earnings Per Share):** EPS has fluctuated significantly over the quarters. There was a substantial increase from 2024-08-05 to 2024-11-04, followed by decreases in subsequent periods. The most recent EPS is 0.19.
* **Revenue:** Revenue has generally increased over the observed period, indicating growing sales. From $0.32B in 2024-08-05, it has grown to $0.54B by 2025-08-04.

### 6. Financial Information

**Revenue and Profitability:**

| Quarter      | Revenue | Profit Margin |
|--------------|---------|---------------|
| 2025-06-30   | $0.54B  | 76.39%        |
| 2025-03-31   | $0.59B  | 73.50%        |
| 2024-12-31   | $0.48B  | 76.81%        |
| 2024-09-30   | $0.40B  | 79.16%        |
| 2024-06-30   | $0.32B  | 81.30%        |

**Capital and Profitability:**

| Quarter      | Equity  | ROE      |
|--------------|---------|----------|
| 2025-06-30   | $0.56B  | 7.55%    |
| 2025-03-31   | $0.55B  | 9.01%    |
| 2024-12-31   | $0.48B  | 5.46%    |
| 2024-09-30   | $0.44B  | 17.18%   |
| 2024-06-30   | $0.36B  | 3.67%    |

**Analysis:**

*   **Revenue and Profitability:** Revenue has generally increased over the past five quarters, reaching $0.54B by 2025-06-30. The profit margin has been relatively high, ranging from 73.50% to 81.30%, indicating strong pricing power and efficient cost management.
*   **Capital and Profitability:** Equity has consistently grown, demonstrating increasing financial stability. The Return on Equity (ROE) has shown variability, peaking at 17.18% in 2024-09-30 and then declining to 7.55% by 2025-06-30. This fluctuation could be due to changes in net income or equity levels.

### 7. Overall Assessment

Hims & Hers Health Inc. (HIMS) presents a mixed picture. While it has significantly outperformed the S&P 500 historically, recent performance indicates a potential short-term downturn.

*   **Positives:** High revenue growth and profit margins, market capitalization growth, previously very strong alpha generation, RSI indicating oversold conditions.
*   **Negatives:** High MDD indicating high volatility, recent downward price momentum (price below 20/60-day moving averages, negative PPO, decline in relative deviation), negative long-term expected return vs. S&P 500, and caution signalled by the hybrid signal. Fluctuation in ROE and EPS.
*   **Key Considerations:** Recent news points to potential significant developments that could impact the stock. Close monitoring of company announcements and financial news is critical.

**Recommendation:** Given the recent downturn and negative long-term outlook, a cautious approach is warranted. Investors should carefully weigh the potential risks and opportunities before making any investment decisions. The high volatility of HIMS makes it a potentially risky investment, and investors should be prepared for significant price swings.
